Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
This study is currently recruiting participants.
Verified May 2013 by Novartis
Study NCT01363232   Information provided by Novartis

First Received on May 24, 2011.   Last Updated on May 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Solid Tumors,
Selected Solid Tumors
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
BKM120 + MEK162
Sponsors listed in this trial
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services